Biotron Limited Appoints Michael Medway as Non-Executive Director
I'm PortAI, I can summarize articles.
Biotron Limited has appointed Michael Medway as a Non-Executive Director, effective immediately. With over 30 years of experience in the professional accounting industry, Medway's expertise is expected to enhance Biotron’s strategic direction and governance. The company focuses on developing antiviral therapies and aims to address unmet medical needs in the biotechnology sector. Current market cap stands at A$2.65M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments